Log in to save to my catalogue

Enzyme replacement therapy for mucopolysaccharidosis VI: evaluation of long-term pulmonary function...

Enzyme replacement therapy for mucopolysaccharidosis VI: evaluation of long-term pulmonary function...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2828556

Enzyme replacement therapy for mucopolysaccharidosis VI: evaluation of long-term pulmonary function in patients treated with recombinant human N-acetylgalactosamine 4-sulfatase

About this item

Full title

Enzyme replacement therapy for mucopolysaccharidosis VI: evaluation of long-term pulmonary function in patients treated with recombinant human N-acetylgalactosamine 4-sulfatase

Publisher

Dordrecht: Dordrecht : Springer Netherlands

Journal title

Journal of inherited metabolic disease, 2010-02, Vol.33 (1), p.51-60

Language

English

Formats

Publication information

Publisher

Dordrecht: Dordrecht : Springer Netherlands

More information

Scope and Contents

Contents

Pulmonary function is impaired in untreated mucopolysaccharidosis type VI (MPS VI). Pulmonary function was studied in patients during long-term enzyme replacement therapy (ERT) with recombinant human arylsulfatase B (rhASB; rhN-acetylgalactosamine 4-sulfatase). Pulmonary function tests prior to and for up to 240 weeks of weekly infusions of rhASB a...

Alternative Titles

Full title

Enzyme replacement therapy for mucopolysaccharidosis VI: evaluation of long-term pulmonary function in patients treated with recombinant human N-acetylgalactosamine 4-sulfatase

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2828556

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2828556

Other Identifiers

ISSN

0141-8955

E-ISSN

1573-2665

DOI

10.1007/s10545-009-9007-8

How to access this item